Literature DB >> 6184098

The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer.

S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6184098     DOI： 10.1007/bf01807891

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

1.  Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.

Authors:  F Cavalli; P Alberto; F Jungi; K Brunner; G Martz
Journal:  Eur J Cancer       Date:  1980       Impact factor: 9.162

2.  Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial.

Authors:  J H Glick; R H Creech; S Torri; C Holroyde; H Brodovsky; R B Catalano; M Varano
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860
  2 in total
  3 in total

Review 1.  An assessment of current achievements in the systemic management of breast cancer.

Authors:  M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

2.  Combined chemo-hormonal therapy in breast cancer: a hypothesis.

Authors:  C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

3.  Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.

Authors:  R Clarke; H W Van den Berg; D G Kennedy; R F Murphy
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.